Foster & Motley Inc. Makes New Investment in HCA Healthcare, Inc. $HCA

Posted by Brenda Bartman on Aug 19th, 2026

Foster & Motley Inc. purchased a new stake in shares of HCA Healthcare, Inc. (NYSE:HCA – Free Report) during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 28,296 shares of the company’s stock, valued at approximately $11,032,000.

Several other large investors have also modified their holdings of HCA. Sumitomo Life Insurance Co. boosted its stake in shares of HCA Healthcare by 1.0% during the fourth quarter. Sumitomo Life Insurance Co. now owns 2,026 shares of the company’s stock valued at $946,000 after purchasing an additional 20 shares in the last quarter. MJP Associates Inc. ADV lifted its holdings in HCA Healthcare by 2.9% during the fourth quarter. MJP Associates Inc. ADV now owns 749 shares of the company’s stock worth $350,000 after buying an additional 21 shares during the period. Cary Street Partners Investment Advisory LLC increased its holdings in shares of HCA Healthcare by 7.5% in the 4th quarter. Cary Street Partners Investment Advisory LLC now owns 300 shares of the company’s stock valued at $140,000 after acquiring an additional 21 shares during the period. Anchyra Partners LLC lifted its stake in shares of HCA Healthcare by 3.7% during the 1st quarter. Anchyra Partners LLC now owns 587 shares of the company’s stock worth $278,000 after purchasing an additional 21 shares during the last quarter. Finally, Plato Investment Management Ltd grew its stake in HCA Healthcare by 0.6% in the fourth quarter. Plato Investment Management Ltd now owns 3,908 shares of the company’s stock valued at $1,833,000 after purchasing an additional 22 shares during the last quarter. Institutional investors own 62.73% of the company’s stock.

HCA Healthcare Stock Performance

Shares of HCA opened at $412.27 on Wednesday. The company has a market capitalization of $89.26 billion, a P/E ratio of 13.80, a P/E/G ratio of 1.40 and a beta of 1.10. The business’s 50-day moving average is $395.07 and its two-hundred day moving average is $445.35. HCA Healthcare, Inc. has a fifty-two week low of $353.99 and a fifty-two week high of $556.52.

HCA Healthcare (NYSE:HCA – Get Free Report) last issued its earnings results on Friday, July 24th. The company reported $7.59 EPS for the quarter, topping analysts’ consensus estimates of $7.56 by $0.03. HCA Healthcare had a negative return on equity of 244.79% and a net margin of 8.77%.The firm had revenue of $20.23 billion for the quarter, compared to the consensus estimate of $19.76 billion. During the same quarter in the prior year, the business earned $6.84 earnings per share. The company’s revenue was up 8.7% compared to the same quarter last year. Analysts forecast that HCA Healthcare, Inc. will post 29.47 EPS for the current year.

HCA Healthcare Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, September 30th. Investors of record on Wednesday, September 16th will be paid a $0.78 dividend. This represents a $3.12 annualized dividend and a dividend yield of 0.8%. The ex-dividend date is Wednesday, September 16th. HCA Healthcare’s payout ratio is currently 10.45%.

Wall Street Analysts Forecast Growth

A number of analysts have recently weighed in on the stock. TD Cowen lowered their price target on shares of HCA Healthcare from $500.00 to $431.00 and set a “buy” rating on the stock in a report on Monday, June 22nd. Oppenheimer cut their price target on shares of HCA Healthcare from $520.00 to $485.00 and set an “outperform” rating on the stock in a report on Monday, July 27th. Raymond James Financial set a $528.00 price objective on HCA Healthcare in a research report on Tuesday, July 7th. Sanford C. Bernstein reaffirmed a “market perform” rating on shares of HCA Healthcare in a research report on Wednesday, July 15th. Finally, Robert W. Baird dropped their price target on HCA Healthcare from $396.00 to $393.00 and set a “neutral” rating on the stock in a research note on Monday, July 27th. Fourteen equities research analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $465.59.

View Our Latest Research Report on HCA Healthcare

HCA Healthcare Company Profile

(Free Report)

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.

Foster & Motley Inc. Makes New Investment in HCA Healthcare, Inc. $HCA

HCA Healthcare Stock Performance

HCA Healthcare Announces Dividend

Wall Street Analysts Forecast Growth

HCA Healthcare Company Profile

See Also

You might be interested in: